Chemed (NYSE:CHE) Issues FY24 Earnings Guidance

Chemed (NYSE:CHE) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $23.00-$23.15 for the period, compared to the consensus EPS estimate of $23.58. Chemed also updated its FY 2024 guidance to 23.000-23.150 EPS.

Chemed Trading Up 0.9 %

Chemed stock traded up $4.71 during trading hours on Thursday, reaching $540.51. 155,613 shares of the stock were exchanged, compared to its average volume of 84,661. The company has a market cap of $8.13 billion, a P/E ratio of 27.31, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44. Chemed has a twelve month low of $525.36 and a twelve month high of $654.62. The stock has a 50 day moving average of $586.71 and a two-hundred day moving average of $569.04.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.37%. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio is 10.11%.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,144 shares of company stock valued at $4,141,679. 3.32% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.